Does Dr. DAVID CAPARRELLI have financial conflicts of interest?

Dr. DAVID CAPARRELLI (M.D.) has received a total of $196,029 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $196,029 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. DAVID CAPARRELLI?

According to CMS Open Payments data, Dr. DAVID CAPARRELLI received funding from ATRICURE ($151,424), MEDTRONIC ($17,719), and ZIMMER BIOMET HOLDINGS ($12,197).

Does Dr. DAVID CAPARRELLI receive research grants or speaking fees?

Dr. DAVID CAPARRELLI has received $196,029 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. DAVID CAPARRELLI

M.D.Real-Time Hydrated

Specialty: Thoracic Surgery (Cardiothoracic Vascular Surgery)

Practice Location: MANCHESTER, NH 03102

NPI Number: 1750434890

LIFETIME INDUSTRY VALUE

$196,029

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. CAPARRELLI is a verified Thoracic Surgery (Cardiothoracic Vascular Surgery) practitioner based in MANCHESTER, NH.

Between 2021 and 2025, Dr. CAPARRELLI had an overall industry promotional and research financial footprint of $196,029 as recorded in the federal CMS Open Payments database.

$196,029 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. CAPARRELLI's primary funding source is ATRICURE, which accounts for $151,424 (representing 77.2% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ATRICURE

Rank 1

$151,424

77.2%

MEDTRONIC

Rank 2

$17,719

ZIMMER BIOMET HOLDINGS

Rank 3

$12,197

6.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.